Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
FR
INT
DA
DE
SV
US
Main menu button
Equipe
Opérations
Contact
Equipe
Opérations
Contact
Actualités
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
Tout
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Tout
21 Déc 2022
Carlsquare weekly market letter: The Swedish property market is under fire! Time to buy?
Equity Research
Carlsquare
15 Déc 2022
Initiation of coverage ALM Equity: From housing developer to corporate builder
Equity Research
ALM Equity
14 Déc 2022
Carlsquare weekly market letter: It is a buyers’ market, again!
Equity Research
Carlsquare
07 Déc 2022
Mrkt Buzz DanCann Pharma: Crucial approval reduces a layer of risk
Equity Research
07 Déc 2022
Carlsquare weekly market letter: Will Santa Claus deliver an IT rally for Christmas?
Equity Research
Carlsquare
05 Déc 2022
Research Update SBB i Norden: Large deal with Brookfield strengthens finances
Equity Research
SBB i Norden
05 Déc 2022
Initiation of Coverage, Abera Bioscience: Advancing with new vaccine technology
Equity Research
Abera Bioscience
30 Nov 2022
Research update Candles Scandinavia, Q2 2022/23: Growth figures are becoming visible
Equity Research
Candles Scandinavia
30 Nov 2022
Carlsquare weekly market letter: The market is at a vulnerable breakpoint ahead of new data
Equity Research
Carlsquare
29 Nov 2022
Mrkt BUZZ Zazz Energy: Two projects reduce uncertainty
Equity Research
28 Nov 2022
CellaVision at Carlsquare Nordic life science investor day
Equity Research
CellaVision
28 Nov 2022
CSAM Health Group at Carlsquare Nordic life science investor day
Equity Research
CSAM Health Group
28 Nov 2022
Herantis Pharma at Carlsquare Nordic life science investor day
Equity Research
Herantis Pharma
28 Nov 2022
Orion Corporation at Carlsquare Nordic life science investor day
Equity Research
Orion Corporation
28 Nov 2022
Alzecure Pharma at Carlsquare Nordic life science investor day
Equity Research
Alzecure Pharma
28 Nov 2022
Monivent at Carlsquare Nordic life science investor day
Equity Research
Moninvent
24 Nov 2022
Research update Zazz Energy, Q3 2022: Increased uncertainty but the share at low levels
Equity Research
23 Nov 2022
Research update Midsummer, Q3 2022: New support for major initiative
Equity Research
Midsummer
23 Nov 2022
Research Update, Elicera Therapeutics: With the next clinical study in sight
Equity Research
Elicera Therapeutics
23 Nov 2022
Carlsquare weekly market letter: Will the consumers raise again?
Equity Research
Carlsquare
1
…
27
28
29
30
31
…
64